Search
for
Sort by
Research 811–840 of 1000+
- Novel C-6 substituted and unsubstituted pregnane derivatives as 5α-reductase inhibitors and their effect on hamster flank organs diameter size
- New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors
- Gene expression of type 2 17β hydroxysteroid dehydrogenase in scalp hairs of hirsute women
- Polycystic Ovarian Morphology is Associated with Hyperandrogenemia and Insulin Resistance in Women with Polycystic Ovary Syndrome (PCOS)
- The therapeutic use of androgens in women
- Clinical applications of antiandrogens
- Neonatal allopregnanolone or finasteride administration modifies hippocampal K+ Cl− co-transporter expression during early development in male rats
- Epitestosterone
- The influence of long-term treatment with cyproterone acetate or a cyproterone acetate-ethinyl oestradiol combination on androgen levels in blood of hirsute women
- Effect of a transcriptional inactive or absent vitamin D receptor on beta-cell function and glucose homeostasis in mice
- Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
- The impact of VDR expression and regulation in vivo
- Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry
- Novel mechanisms for the vitamin D receptor (VDR) in the skin and in skin cancer
- Establishment of type II 5α-reductase over-expressing cell line as an inhibitor screening model
- Cardiac biopsy in myocarditis
- 11 Treatment of hirsutism and acne with cyproterone acetate
- Modeling the pharmacodynamics of nandrolone doping drug and implications for anti‐doping testing
- Stress-Induced Deoxycorticosterone-Derived Neurosteroids Modulate GABA<sub>A</sub>Receptor Function and Seizure Susceptibility
- Hirsutism in the Adolescent Female
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3
- Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3
- Testosterone therapy for transgender men
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation
- In vitro and clinical evaluation of umbilical cord‐derived mesenchymal stromal cell‐conditioned media for hair regeneration
- Androgen replacement therapy in women
- Biotransformation of Finasteride (MK-0906) by Selenastrum capricornutum (Green Algae)
- Chapter 23. Therapeutic Control of Androgen Action